These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Age-related macular degeneration therapy: a review. Ammar MJ; Hsu J; Chiang A; Ho AC; Regillo CD Curr Opin Ophthalmol; 2020 May; 31(3):215-221. PubMed ID: 32205470 [TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of the DNA base excision repair genes MUTYH and hOGG1 and age-related macular degeneration. Synowiec E; Blasiak J; Zaras M; Szaflik J; Szaflik JP Exp Eye Res; 2012 May; 98():58-66. PubMed ID: 22469746 [TBL] [Abstract][Full Text] [Related]
8. Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. Jun G; Nicolaou M; Morrison MA; Buros J; Morgan DJ; Radeke MJ; Yonekawa Y; Tsironi EE; Kotoula MG; Zacharaki F; Mollema N; Yuan Y; Miller JW; Haider NB; Hageman GS; Kim IK; Schaumberg DA; Farrer LA; DeAngelis MM PLoS One; 2011; 6(10):e25775. PubMed ID: 21998696 [TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms in complement component 3 with age-related macular degeneration in an Iranian population. Bonyadi M; Mohammadian T; Jabbarpoor Bonyadi MH; Fotouhi N; Soheilian M; Javadzadeh A; Moein H; Yaseri M Ophthalmic Genet; 2017; 38(1):61-66. PubMed ID: 27029644 [TBL] [Abstract][Full Text] [Related]
10. Drugs in Phase II clinical trials for the treatment of age-related macular degeneration. Tolentino MJ; Dennrick A; John E; Tolentino MS Expert Opin Investig Drugs; 2015 Feb; 24(2):183-99. PubMed ID: 25243494 [TBL] [Abstract][Full Text] [Related]